现场直击|2025年国家医保谈判首日，有企业代表称价格“挺紧的”

Core Viewpoint - The negotiation for the 2025 National Medical Insurance Directory and commercial insurance innovative drug directory prices has officially started in Beijing, lasting 4 to 5 days, with some drugs applying for both directories simultaneously [1]. Group 1: Negotiation Details - The negotiation began at 8:30 AM, with representatives arriving as early as 7:30 AM, indicating high interest and participation [3]. - The atmosphere at the venue was described as relaxed, with representatives discussing market conditions and the weather while waiting [7]. - Some representatives expressed that the pricing negotiations are quite tight, indicating limited room for price increases [8]. Group 2: Participating Companies - The negotiation involves both foreign and domestic pharmaceutical companies, including major players like Pfizer, Boehringer Ingelheim, and Novartis, among others [10]. - A total of 535 drugs passed the formal review for the basic directory, with 311 being outside the directory and 224 within it, alongside 121 high-value drugs approved for the commercial insurance innovative drug directory [10].